With the successful 2011 integration of Falcon Pharmaceuticals, Ltd., an affiliate of Alcon Laboratories Inc., Sandoz became the leading manufacturer and marketer of generic ophthalmic (eye) and otic (ear) products in the US and worldwide. This business created another pillar for Sandoz’s long-term differentiated products growth strategy, building on existing global leadership positions in biosimilars, generic injectables, a...
With the successful 2011 integration of Falcon Pharmaceuticals, Ltd., an affiliate of Alcon Laboratories Inc., Sandoz became the leading manufacturer and marketer of generic ophthalmic (eye) and otic (ear) products in the US and worldwide. This business created another pillar for Sandoz’s long-term differentiated products growth strategy, building on existing global leadership positions in biosimilars, generic injectables, and generic anti-infectives, as well as a powerful generic respiratory pipeline. (As of July 2012, Sandoz is also the US and global leader in generic dermatology, following its acquisition of Fougera Pharmaceuticals).
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.